Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹25 Cr₹61 Cr₹101 Cr₹135 Cr₹143 Cr

What is the latest Total Non-Current Liabilities ratio of NATCO PHARMA ?

The latest Total Non-Current Liabilities ratio of NATCO PHARMA is ₹25 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹25 Cr
Mar2024₹61 Cr
Mar2023₹101 Cr
Mar2022₹135 Cr
Mar2021₹143 Cr

How is Total Non-Current Liabilities of NATCO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹25 Cr
-59.18
Mar2024 ₹61 Cr
-39.30
Mar2023 ₹101 Cr
-25.61
Mar2022 ₹135 Cr
-5.46
Mar2021 ₹143 Cr -

Compare Total Non-Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,569.8 Cr -2.4% -9.2% -37.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹381,326.0 Cr -2.8% -7.5% -12.2% Stock Analytics
DIVIS LABORATORIES ₹160,299.0 Cr -0.6% -5.5% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,821.0 Cr -2.5% 3.5% 21.1% Stock Analytics
CIPLA ₹106,655.0 Cr -3.7% -11.7% -8.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,861.0 Cr -0.7% -4.7% -5.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.4%

-9.2%

-37.1%

SENSEX

0.8%

-2.9%

8.1%


You may also like the below Video Courses